Dr. Lee oversees MD Anderson’s clinical divisions, national cancer network and international collaborations, advancing institutional strategy to expand access to research-driven oncology care. He leads efforts to enhance virtual care, improve timely patient access and strengthen survivorship models while supporting recruitment, engagement and resilience across the physician workforce. As the leader of MD Anderson’s cancer network, he guides partnerships with seven U.S. organizations to elevate quality through shared standards, clinical trial access and real-time multidisciplinary tumor boards, connecting physicians across sites. He previously served as chair of surgical oncology and vice president for medical and academic affairs within the cancer network, where he helped redesign network strategy, build academic infrastructure and activate major national partnerships. Dr. Lee has authored more than 600 peer-reviewed publications and maintained a peer-reviewed funded laboratory research program focused on melanoma genetics and immunotherapy development. His leadership supports MD Anderson’s sustained No. 1 national ranking in cancer care by U.S. News & World Report and continued 5-star performance in Vizient’s quality and accountability scorecard.
